SML0569
RO-3306
≥98% (HPLC), powder, CDK1 inhibitor
别名:
(5Z)-5-喹啉-6-基甲亚基-2-[(噻吩-2-基甲基)-氨基]-噻唑-4-酮, 5-(6-喹啉基甲亚基)-2-[(2-噻吩基甲基)氨基]-4(5H)-噻唑酮
登录查看公司和协议定价
关于此项目
经验公式（希尔记法）:
C18H13N3OS2
CAS Number:
分子量:
351.45
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77
Product Name
RO-3306, ≥98% (HPLC)
质量水平
方案
≥98% (HPLC)
表单
powder
颜色
off-white to brown
溶解性
DMSO: 5 mg/mL, clear
储存温度
2-8°C
SMILES字符串
O=C1N=C(NCC2=CC=CS2)S/C1=C\C3=CC4=C(C=C3)N=CC=C4
InChI
1S/C18H13N3OS2/c22-17-16(24-18(21-17)20-11-14-4-2-8-23-14)10-12-5-6-15-13(9-12)3-1-7-19-15/h1-10H,11H2,(H,20,21,22)/b16-10-
InChI key
XOLMRFUGOINFDQ-YBEGLDIGSA-N
相关类别
应用
RO-3306已可用于：
- 研究CA4介导的细胞毒性在有丝分裂阻滞中的重要性
- 在细胞周期同步化中进行蛋白质组学研究
- 作为CDK1抑制剂，防止进入早期有丝分裂
生化/生理作用
CDK1（细胞周期蛋白依赖性激酶1）被认为是细胞分裂的“主要开关”，它能够维持细胞的有丝分裂状态。
RO-3306是一种选择性ATP竞争性CDK1抑制剂。
RO-3306是一种选择性ATP竞争性CDK1抑制剂。 它能够抑制CDK1/cyclin B1的活性，Ki值为35 nM，它对CDK1/cyclin B1的选择性是CDK2/cyclin E的近10倍，是CDK4/cyclin D的50倍以上。RO-3306已可用于使细胞周期阻滞在G2/M期。
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
历史批次信息供参考:
分析证书(COA)
Lot/Batch Number
Tamara B Garcia et al.
Leukemia research, 64, 30-33 (2017-11-28)
Inhibition of WEE1 is emerging as a promising chemosensitization strategy in many cancers including acute leukemia. Our lab and others have demonstrated that a small-molecule inhibitor of WEE1, AZD1775, sensitizes acute leukemia cells to cytarabine; however, a mechanism of combinatorial
Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1.
Vassilev L T, et al.
Proceedings of the National Academy of Sciences of the USA, 103(28), 10660-10665 (2006)
BRCA2 suppresses replication stress-induced mitotic and G1 abnormalities through homologous recombination.
Feng W and Jasin M
Nature Communications, 8(1), 525-525 (2017)
Structurally simplified biphenyl combretastatin A4 derivatives retain in vitro anti-cancer activity dependent on mitotic arrest.
Tarade D, et al.
PLoS ONE, 12(3), e0171806-e0171806 (2017)
Visualization of human karyopherin beta-1/importin beta-1 interactions with protein partners in mitotic cells by co-immunoprecipitation and proximity ligation assays.
Francesco L, et al.
Scientific Reports, 8(1), 1850-1850 (2018)
商品
Review properties, activators and inhibitors, and available products for researching cyclin-dependent kinases (CDKs).
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持